article · 2019
First real world evidence data for the new monoclonal antibody Erenumab from specialized migraine centers in Germany
0 citationsDOI: https://doi.org/10.1016/j.jns.2019.10.1808
Article
Article detail, metadata, authors, and available full-text links.
Paper reader
Loading paper...